Wireless motility capsule in the diagnosis and evaluation of gastroparesis or slow-transit constipation

BlueCross BlueShield Association
Record ID 32013000450
English
Authors' objectives: The objective of this assessment is to determine whether the wireless motility capsule (SmartPill®) improves health outcomes when used in the diagnosis and evaluation of gastroparesis and constipation, in patients presenting with clinical symptoms of those conditions.
Authors' recomendations: The limited body of evidence on the diagnostic characteristics of SmartPill® does reveal correlations between SmartPill® and other tests that indicate some capability to distinguish diseased from nondiseased persons. However, because of the types of subjects included in the studies, particularly healthy patients, and the lack of a reference standard for the disease of interest (slow-transit constipation) in some studies, the diagnostic characteristics of SmartPill® are uncertain. There are no studies that ascertain whether use of the SmartPill® in addition to or instead of alternative methods of diagnosis improves patient outcomes.
Details
Project Status: Completed
Year Published: 2012
English language abstract: An English language summary is available
Publication Type: Not Assigned
Country: United States
MeSH Terms
  • Blue Cross Blue Shield Insurance Plans
  • Clinical Trials as Topic
  • Device Approval
  • Gastric Emptying
  • Technology Assessment, Biomedical
  • Treatment Outcome
  • United States
  • Capsule Endoscopy
  • Constipation
  • Gastrointestinal Transit
  • Gastroparesis
  • Monitoring, Physiologic
Contact
Organisation Name: BlueCross BlueShield Association
Contact Address: BlueCross BlueShield Association, Technology Evaluation Center, 225 North Michigan Ave, Chicago, Illinois, USA. Tel: 888 832 4321
Contact Name: tec@bcbsa.com
Contact Email: tec@bcbsa.com
Copyright: BlueCross BlueShield Association (BCBS)
This is a bibliographic record of a published health technology assessment from a member of INAHTA or other HTA producer. No evaluation of the quality of this assessment has been made for the HTA database.